News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point

Specialty: Multispecialty
Allergy & Immunology
Anesthesiology
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Today on Medscape
Business of Medicine
Medical Lifestyle
Science & Technology
Medical Students
Nurses
Pharmacists
Residents
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape

    No Results

      Thursday, October 6, 2022
      News & Perspective Drugs & Diseases CME & Education Academy Video Decision Point

      From Medscape Oncology

      Medscape Medical News from the:

      2011 European Multidisciplinary Cancer Congress (EMCC)

      September 23 - 27, 2011; Stockholm, Sweden

      This coverage is not sanctioned by, nor a part of the European Society for Medical Oncology, the European Cancer Organisation, or the European Society for Radiotherapy and Oncology.

      Meeting Highlights at a Glance

      Top News Stories From the 2011 EMCC
      Research presented included practice-changing results from a large number of late-breaking phase 3 clinical trials, including SECRAB, BOLERO-2, and a study of the investigational radiopharmaceutical radium-223 chloride in prostate cancer.

      Oncology Insights: The Wrap-up

      EMCC Wrap-up: mTOR and More
      Drs. David Kerr and Jean-Charles Soria discuss the highlights of the EMCC meeting, focusing on practice-changing trials.

      Conference News

      Medscape Oncology©  WebMD, LLC

      Medscape Oncology Insights

      Wanted: Better Tumor Marksmanship
      Jean-Charles Soria, MD

      T-DM1: Why So Much Interest?
      Gunter von Minckwitz, MD,
      PhD;
      Fabrice André, MD, PhD

      Lung Cancer: A Shooting Gallery of Targets
      Giorgio V. Scagliotti, MD, PhD;
      Thierry Le Chevalier, MD

      Prostate Cancer: A Treatment Renaissance
      Johann S. de Bono, PhD, MSc

      Colorectal Cancer: New Data, New Insights
      Eric Van Cutsem, MD, PhD

      Ovarian Cancer: New Treatment Options
      Stanley B. Kaye, MD

      Pre-Meeting Expert Commentary

      Preview of Practice-Changing Data From ECCO/ESMO
      David J. Kerr, MD

      Find Us On
      About
      About Medscape Privacy Policy Editorial Policy Cookies Terms of Use Advertising Policy Help Center
      Membership
      Become a Member About You Professional Information Newsletters & Alerts Market Research
      App
      Medscape
      WebMD Network
      Medscape Live Events WebMD MedicineNet eMedicineHealth RxList WebMD Corporate
      Editions
      English Deutsch Español Français Português
      All material on this website is protected by copyright, Copyright © 1994-2022 by WebMD LLC. This website also contains material copyrighted by 3rd parties.